PAUL N. WITUSCHEK

Paul N. Wituschek is a globally recognized executive, investor, entrepreneur and board advisor with a distinguished track record of driving transformational growth, M&A execution, and enterprise value creation across the Pharma Services, Healthcare and Life Sciences, sectors.

Over the course of his career, Paul has operated at the intersection of strategy, capital, and execution—partnering with private equity sponsors, institutional investors, and executive leadership teams to scale platforms, professionalize commercial organizations, lead carve-outs, and unlock operational leverage. His expertise spans global CDMOs, CROs, Clinical Services, Regulatory & Medical Affairs, Packaging, Healthcare IT, and specialty pharma services, with deep domain knowledge across both Rx, Gx and Consumer Health markets.

\Over a multi-decade career, Paul has held executive and board leadership roles at premier global organizations including ICON Clinical Research, Catalent Pharma Solutions, Penn Pharma / PCI Pharma, and Wolters Kluwer Health, where he helped generate billions in shareholder value and contributed to record-setting market capitalization growth.

Today, Paul is widely regarded as a trusted strategic advisor to private equity sponsors, institutional investors, and executive leadership teams navigating complex carve-outs, growth inflection points, and exit strategies.

A diversified global portfolio of companies and investments in the healthcare, retail and sports sectors.

Paul is the Founder, Chairman, and CEO of Expert Insights Group, a global advisory and investment platform focused exclusively on Healthcare, Life Sciences, and Pharma Services.

Under his leadership, the Group has become one of the sector’s most respected independent advisory platforms, serving private equity firms, strategic acquirers, boards, and growth-stage companies worldwide.

Paul has served in senior executive leadership roles including Chief Commercial Officer and Board Advisor across multiple global CDMOs, CROs, and healthcare enterprises. He has led:

·  Global commercial expansions across North America, Europe, and Asia

·  Strategic carve-outs and stand-up transformations

·  Post-merger integration initiatives

·  Revenue acceleration programs generating substantial EBITDA expansion

·  Complex cross-border transactions and private equity exits

His leadership approach combines operational intensity, disciplined governance, and growth-focused commercial strategy.

As a Board Member and Trusted Advisor, Paul provides governance, capital strategy, and growth guidance to companies at critical inflection points. His work spans:

·  Private equity portfolio companies

·  Founder-led growth businesses

·  Institutional investor-backed platforms

·  Carve-out and turnaround situations

He is particularly known for aligning leadership teams, de-risking commercial execution, and positioning companies for premium valuation outcomes.

Paul’s influence extends beyond executive leadership. He is a recognized thought leader across Pharma Services and Healthcare, frequently advising senior investment teams, industry executives, and institutional capital providers on market dynamics, consolidation trends, and growth strategies. His ability to combine strategic vision with hands-on execution has made him one of the most sought-after advisors in the global Pharma Services ecosystem.

Paul is a serial entrepreneur and founder of multiple high-growth ventures spanning global healthcare advisory, luxury athleisure, and sports club enterprises. Across each platform, he has built scalable business models grounded in disciplined governance, strategic capital allocation, and long-term value creation. Collectively, these enterprises have generated significant revenue growth, strengthened brand equity, and created durable long-term value for stakeholders.